Skip to content
Review

How Can QM Methods Be Used to Guide Synthesis Planning in Drug Discovery?

2026 · Methods in molecular biology · Vol 3061, pp. 311-322 · 0 citations
Medicine

TL;DR

This chapter reviews how QM methods can guide synthesis planning by complementing chemist expertise, literature precedent, and computer-assisted synthesis planning (CASP) tools and demonstrates how QM-driven synthesis planning can support the identification of synthetically accessible drug candidates and advance progress in making the compounds.

View source

Similar papers

Review 2026

Perspectives on Hybridizing Quantum Mechanics and Artificial Intelligence for Drug Design.

This chapter presents the perspective of computational chemists at Sygnature Discovery on the growing need to integrate quantum mechanics (QM) with artificial intelligence (AI) to improve the efficiency and effectiveness of modern drug design.

Alexander Heifetz, Girinath G. Pillai, M. Quareshy et al. · 0 citations
Review 2026

Quantum Chemistry in Drug Design: Applications, Challenges, and the Need for Speed.

Key QM applications-torsional profiles, spectra prediction, reactivity analysis, and modeling of non-covalent interactions-highlighting their impact and limitations are reviewed, illustrating the trade-off between speed and accuracy.

C. Tautermann, M. Degroote, Benjamin Ries · 0 citations
Aug 2026

Systematic Benchmarking of AI-Based Molecular Generation Models for Structure-Based Drug Design

A state-aware functional classifier (SAFC) is developed that integrates molecular dynamics derived receptor ensembles, ensemble docking and protein ligand interaction graphs that provides dynamics-aware functional activity rankings for generated molecules that were partly complementary to docking, drug-likeness and syn...

H. Kumar, Zheng-Xiao Yang, Yankai Yu et al. · 0 citations
2026

Open-Sourced In Silico Drug Screening.

This chapter describes a structure-based computational approach to perform high-throughput ligand screens of chemical libraries using open-source software programs and illustrates this workflow with the enzymatic molecular target NAD(P)H:quinone oxidoreductase1 (NQO1), which is overexpressed in a number of human solid...

Audrey G. Fikes, Melissa C. Srougi · 0 citations
Aug 2026

Evaluating BioEmu-Generated Kinase Ensembles Reveals Structure Selection as the Virtual Screening Bottleneck.

It is shown that prospective structure selection, rather than structure generation, represents the primary bottleneck in ensemble-based VS, highlighting an urgent need for novel structural descriptors to identify high-performing conformations.

Jaeoh Shin, K. Joo, Jejoong Yoo · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.